In-depth research guides covering peptides, compounds, and laboratory supplies. For research use only.
Migraine research has explored BPC-157 for nitric oxide modulation, Selank for stress-axis effects, and Semax for cortical mechanisms. Here’s what preclinical data shows about peptides and migraine biology.
GHK-Cu and retinol are two of the most evidence-backed skin rejuvenation ingredients. Both stimulate collagen but through different mechanisms. This research comparison covers tolerability, efficacy, and whether they can be combined.
Research has explored Selank, Semax, and DSIP for seizure-related mechanisms including GABAergic modulation, post-seizure neuroprotection, and neuroinflammation reduction. Here’s what preclinical data shows.
Huntington’s disease has no disease-modifying treatment. Research explores Semax, Selank, and Cerebrolysin for their neuroprotective and anti-inflammatory properties in HD-relevant models.
What Is Pinealon? Pinealon is a synthetic tripeptide with the amino acid sequence Glu-Asp-Arg (glutamic acid–aspartic acid–arginine), commonly abbreviated as EDR.
Survodutide represents a distinctive approach in the evolving landscape of multi-receptor metabolic peptides.
GHK-Cu is one of the most studied skin peptides. Research shows cellular changes begin within days, but meaningful measurable skin improvements typically emerge over 4–12 weeks. Here’s the full timeline.
TB-500 and PRP both target tissue repair but through very different mechanisms. This research comparison breaks down how they work, where they differ, and what the evidence shows.
ALS research has explored BPC-157 for neuroprotection and SS-31 for mitochondrial stabilization. Here’s what preclinical studies show about peptides and motor neuron disease.
Research in animal models suggests BPC-157, Semax, and Cerebrolysin may support neuroprotection and reduce neuroinflammation in processes relevant to multiple sclerosis. Here’s what the science shows.
